Scholarworks Repository

The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome

Show simple item record

dc.contributor.author Uthman I.
dc.contributor.author Shamseddine A.
dc.contributor.author Taher A.
dc.contributor.editor
dc.date Aug-2005
dc.date.accessioned 2017-10-05T15:38:18Z
dc.date.available 2017-10-05T15:38:18Z
dc.date.issued 2005
dc.identifier 10.1016/j.transci.2004.10.025
dc.identifier.isbn
dc.identifier.issn 14730502
dc.identifier.uri http://hdl.handle.net/10938/16261
dc.description.abstract The catastrophic antiphospholipid syndrome (CAPS) is a life-threatening sub-entity of the antiphospholipid syndrome (APS) resulting in multiorgan failure and a mortality rate that may reach 50percent. The optimal treatment regimen for CAPS is unknown. To evaluate the benefit of therapeutic plasma exchange (TPE) therapy in CAPS, we undertook a computer-assisted (MEDLINE, National Library of Medicine, Bethesda, MD) search of the literature to locate all cases of CAPS (case reports and reviews) treated with TPE. In view of the published literature so far, TPE has shown reasonable therapeutic benefits and improved survival for patients with CAPS. The use of this technique, along with anticoagulation and if needed pharmacological immunosuppression, should be considered for the acute management of patients who present with this life-threatening condition. © 2005 Elsevier Ltd. All rights reserved.
dc.format.extent
dc.format.extent Pages: (11-17)
dc.language English
dc.publisher OXFORD
dc.relation.ispartof Publication Name: Transfusion and Apheresis Science; Publication Year: 2005; Volume: 33; no. 1; Pages: (11-17);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome
dc.type Article
dc.contributor.affiliation Uthman, I., Department of Internal Medicine, Division of Rheumatology, American University of Beirut Medical Center (AUBMC), Hamra Street, Beirut 1107 2802, Lebanon
dc.contributor.affiliation Shamseddine, A., Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center (AUBMC), Hamra Street, Beirut 1107 2802, Lebanon
dc.contributor.affiliation Taher, A., Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center (AUBMC), Hamra Street, Beirut 1107 2802, Lebanon
dc.contributor.authorAddress Taher, A.; Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center (AUBMC), Hamra Street, Beirut 1107 2802, Lebanon; email: ataher@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Rheumatology;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Rheumatology
dc.contributor.authorEmail ataher@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Uthman, I
dc.contributor.authorInitials Shamseddine, A
dc.contributor.authorInitials Taher, A
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Taher, A (reprint author), Amer Univ Beirut, Med Ctr, Div Hematol Oncol, Dept Internal Med, Hamra St, Beirut 1107 2802, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Akioka Y, 1998, Ther Apher, V2, P236, DOI 10.1111-j.1744-9987.1998.tb00110.x; Asherson Ronald A, 2003, Curr Rheumatol Rep, V5, P395, DOI 10.1007-s11926-003-0031-7; Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097-00005792-200111000-00002; Asherson RA, 1996, LUPUS, V5, P414; ASHERSON RA, 1992, J RHEUMATOL, V19, P508; Asherson RA, 1998, MEDICINE, V77, P195, DOI 10.1097-00005792-199805000-00005; Asherson RA, 2003, LUPUS, V12, P530, DOI 10.1191-0961203303lu394oa; Bandarenko N, 1998, J CLIN APHERESIS, V13, P133, DOI 10.1002-(SICI)1098-1101(1998)13:3133::AID-JCA73.0.CO;2-Z; Braun N, 2002, THER APHER, V6, P471, DOI 10.1046-j.1526-0968.2002.00408.x; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; Flamholz R, 1999, J CLIN APHERESIS, V14, P171, DOI 10.1002-(SICI)1098-1101(1999)14:4171::AID-JCA33.0.CO;2-5; FRAMPTON G, 1987, LANCET, V2, P1023; FULCHER D, 1989, LANCET, V2, P171; HESS DC, 1992, J RHEUMATOL, V19, P1474; INGRAM SB, 1987, ARTHRITIS RHEUM, V30, P1167, DOI 10.1002-art.1780301013; Kitchens CS, 1998, AM J MED, V104, P381, DOI 10.1016-S0002-9343(98)00061-8; KOBAYASHI S, 1992, ANN RHEUM DIS, V51, P399, DOI 10.1136-ard.51.3.399; Koo AP, 2000, J CLIN APHERESIS, V15, P18, DOI 10.1002-(SICI)1098-1101(2000)15:1-218::AID-JCA33.0.CO;2-R; Koschmieder S, 2003, BLOOD COAGUL FIBRIN, V14, P395, DOI 10.1097-01.mbc.0000061302.06975.a9; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056-NEJMra002974; McLeod BC, 2000, J CLIN APHERESIS, V15, P1; McLeod BC, 1999, TRANSFUSION, V39, P282, DOI 10.1046-j.1537-2995.1999.39399219285.x; Miyamae T, 1999, Ryumachi, V39, P591; Moll S, 2003, AM J HEMATOL, V72, P278, DOI 10.1002-ajh.10268; Nagayama K, 1997, INTERNAL MED, V36, P661, DOI 10.2169-internalmedicine.36.661; Otsubo S, 2002, INTERNAL MED, V41, P725, DOI 10.2169-internalmedicine.41.725; Paydas S, 1997, J CLIN PATHOL, V50, P261, DOI 10.1136-jcp.50.3.261; Roberts G, 2003, LUPUS, V12, P251, DOI 10.1191-0961203303lu378xx; RUFFATTI A, 1994, J INTERN MED, V235, P81; Ruiz-Arguelles GJ, 1998, LUPUS, V7, P49, DOI 10.1191-096120398678919633; Sachais BS, 2002, J CLIN APHERESIS, V17, P138, DOI 10.1002-jca.10016; Satomi A, 1998, Ther Apher, V2, P157, DOI 10.1111-j.1744-9987.1998.tb00095.x; Smith JW, 2003, TRANSFUSION, V43, P820, DOI 10.1046-j.1537-2995.2003.00397.x; VIVALDI P, 1994, HAEMATOLOGICA, V79, P173; von Baeyer H, 2003, THER APHER DIAL, V7, P127, DOI 10.1046-j.1526-0968.2003.00004.x; Wallace DJ, 1999, LUPUS, V8, P174, DOI 10.1191-096120399678847669; Waterer G W, 1999, Respirology, V4, P405, DOI 10.1046-j.1440-1843.1999.00212.x
dc.description.citedCount 32
dc.description.citedTotWOSCount 21
dc.description.citedWOSCount 21
dc.format.extentCount 7
dc.identifier.articleNo
dc.identifier.coden TASRC
dc.identifier.pubmedID 15951243
dc.identifier.scopusID 22144480903
dc.identifier.url
dc.publisher.address THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Transfus. Apher. Sci.
dc.relation.ispartOfIssue 1
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Transfusion and Apheresis Science
dc.relation.ispartofPubTitleAbbr Transfus. Apheresis Sci.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 33
dc.source.ID WOS:000231157800003
dc.type.publication Journal
dc.subject.otherAuthKeyword Catastrophic antiphospholipid syndrome
dc.subject.otherAuthKeyword Therapeutic plasma exchange
dc.subject.otherChemCAS cyclophosphamide, 50-18-0
dc.subject.otherChemCAS heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5
dc.subject.otherChemCAS immunoglobulin, 9007-83-4
dc.subject.otherChemCAS methylprednisolone, 6923-42-8, 83-43-2
dc.subject.otherChemCAS ticlopidine, 53885-35-1, 55142-85-3
dc.subject.otherIndex anticoagulant agent
dc.subject.otherIndex cyclophosphamide
dc.subject.otherIndex heparin
dc.subject.otherIndex immunoglobulin
dc.subject.otherIndex methylprednisolone
dc.subject.otherIndex steroid
dc.subject.otherIndex ticlopidine
dc.subject.otherIndex antiphospholipid syndrome
dc.subject.otherIndex article
dc.subject.otherIndex blood transfusion reaction
dc.subject.otherIndex chill
dc.subject.otherIndex clinical trial
dc.subject.otherIndex diaphoresis
dc.subject.otherIndex evaluation
dc.subject.otherIndex human
dc.subject.otherIndex immunosuppressive treatment
dc.subject.otherIndex medical literature
dc.subject.otherIndex MEDLINE
dc.subject.otherIndex nausea
dc.subject.otherIndex plasmapheresis
dc.subject.otherIndex respiratory distress
dc.subject.otherIndex rigor
dc.subject.otherIndex seizure
dc.subject.otherIndex survival
dc.subject.otherIndex tetany
dc.subject.otherIndex treatment outcome
dc.subject.otherIndex vomiting
dc.subject.otherIndex Antiphospholipid Syndrome
dc.subject.otherIndex Catastrophic Illness
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Male
dc.subject.otherIndex Plasma Exchange
dc.subject.otherKeywordPlus THROMBOTIC THROMBOCYTOPENIC PURPURA
dc.subject.otherKeywordPlus SYSTEMIC-LUPUS-ERYTHEMATOSUS
dc.subject.otherKeywordPlus ANTICARDIOLIPIN ANTIBODIES
dc.subject.otherKeywordPlus APHERESIS
dc.subject.otherKeywordPlus PLASMAPHERESIS
dc.subject.otherKeywordPlus ANTICOAGULATION
dc.subject.otherKeywordPlus PREGNANCY
dc.subject.otherKeywordPlus PATIENT
dc.subject.otherKeywordPlus IMMUNOSUPPRESSION
dc.subject.otherKeywordPlus PREDNISOLONE
dc.subject.otherWOS Hematology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Scholarworks


Browse

My Account